| Oct 15 |
Atara Biotherapeutics (ATRA) Upgraded to Buy: Here's What You Should Know
|
| Oct 4 |
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
| Sep 13 |
Redmile Group, LLC Expands Stake in Atara Biotherapeutics Inc
|
| Sep 4 |
Atara Biotherapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
|
| Sep 3 |
Atara Biotherapeutics announces $36M registered direct offering
|
| Sep 3 |
Atara Biotherapeutics Announces $36 Million Registered Direct Offering
|
| Aug 14 |
Atara Biotherapeutics Second Quarter 2024 Earnings: Misses Expectations
|
| Aug 12 |
Atara Biotherapeutics (ATRA) Reports Q2 Loss, Misses Revenue Estimates
|
| Aug 12 |
Atara Biotherapeutics GAAP EPS of -$3.10 misses by $1.54, revenue of $28.64M misses by $8.45M
|
| Aug 12 |
Atara Biotherapeutics: Q2 Earnings Snapshot
|
